Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by donmayneon May 02, 2022 7:35am
122 Views
Post# 34646805

RE:Mgmt circ on sedar

RE:Mgmt circ on sedarAlso, their Stock Compensation Plans are egregious.  If the share price were to return to its all time high, the senior management team will profit by more than $25 Million.  Every year, new awards.  When the price fell, it gave them opportunity for lower exercise prices.  Meanwhile the retail shareholders suffered huge losses making VMD one of the worst performers in many portfolios.

Options granted to management insiders
Date of Grant Options granted Exercise Price Expiry date 1/3 Vesting
04-Jan-18      563,737 2.27 Cdn 04-Jan-28 Yrs 1, 2 & 3
17-Jan-19      786,452 5.49 Cdn 17-Jan-29 Yrs 1, 2 & 3
17-Jan-20      640,835 7.44 Cdn 17-Jan-30 Yrs 1, 2 & 3
21-Jan-21      524,711 10.63 Cdn 21-Jan-31 Yrs 1, 2 & 3
18-Jan-22      371,102 5.21 US 18-Jan-32 Yrs 1, 2 & 3
18-Jan-22      252,345 RSUs 18-Jan-25 Yrs 1, 2 & 3
18-Jan-22      123,692 Phantom Sh 18-Jan-25 Yrs 1, 2 & 3



<< Previous
Bullboard Posts
Next >>